References
- World Health Organization (WHO). Weekly epidemiological update on COVID-19-27 July 2021. 2021 [accessed 2021 Aug 5]. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19—27-july-2021.
- National Bureau of Statistics of China. The sixth national census. 2011 Apr 28 [accessed 2020 July 1]. http://www.stats.gov.cn/tjsj/pcsj/rkpc/6rp/indexch.htm.
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for disease control and prevention. JAMA. 2020;323:1239–42. doi:10.1001/jama.2020.2648.
- CDC COVID-19 Response Team. Coronavirus disease 2019 in children-United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:422–26 [assessed 2020 July 1]. https://www.cdc.gov/mmwr/volumes/69/wr/mm6914e4.htm
- Ludvigsson JF. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults. Acta Paediatrica. 2020;109:1088–95. doi:10.1111/apa.15270.
- World Health Organization (WHO). Draft landscape of COVID-19 candidate vaccines. 2020 Jun 11 [accessed 2020 Jun 13]. https://www.who.int/who-documents-detail/draft-landscape-of-covid-19-candidate-vaccines.
- World Health Orgnization (WHO). Status of COVID-19 vaccines within WHO EUL/PQ evaluation process. 2021 Jul 15 [accessed 2021 Aug 12]. https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_15July2021.pdf.
- Centers for Disease Control and Prevention. COVID-19 vaccines for children and teens. 2021 Jun 23 [accessed 2021 Aug 12]. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/adolescents.html.
- The State Council Information office The People’s Republic of China. China approves emergency use of domestic vaccines for 3–17 age group. 2021 Jun 12 [accessed 2021 Aug 12]. http://english.scio.gov.cn/pressroom/2021-06/12/content_77564263.htm.
- The State Council Information office The People’s Republic of China. China to extend mass vaccination program to minors aged 12–17. 2021 Jul 18 [accessed 2021 Aug 12]. http://english.www.gov.cn/news/topnews/202107/18/content_WS60f361e3c6d0df57f98dd2ca.html.
- Brewer NT, Chapman GB, Gibbons FX, Gerrard M, McCaul KD, Weinstein ND. Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. Health Psychol. 2007;26:136. doi:10.1037/0278-6133.26.2.136.
- Shahrabani S, Benzion U. Workplace vaccination and other factors impacting influenza vaccination decision among employees in Israel. IJERPH. 2010;7:853–69. doi:10.3390/ijerph7030853.
- He L, Liao QY, Huang YQ, Feng S, Zhuang XM. Parents’ perception and their decision on their children’s vaccination against seasonal influenza in Guangzhou. Chin Med J (Engl). 2015;128:327. doi:10.4103/0366-6999.150099.
- Yang R, Penders B, Horstman K. Addressing vaccine hesitancy in China: a scoping review of Chinese Scholarship. Vaccines. 2020;8:2. doi:10.3390/vaccines8010002.
- Chen B, Zhang JM, Jiang Z, Shao J, Jiang T, Wang Z, Liu K, Tang S, Gu H, Jiang J. Media and public reactions toward vaccination during the ‘hepatitis B vaccine crisis’ in China. Vaccine. 2015;33:1780–85. doi:10.1016/j.vaccine.2015.02.046.
- Halimi M, Alishahi M, Abbaspour MR, Ghorbanpoor M, Tabandeh MR. Valuable method for production of oral vaccine by using alginate and chitosan against Lactococcus garvieae/Streptococcus iniae in rainbow trout (Oncorhynchus mykiss). Fish Shellfish Immunol. 2019;90:431–39. doi:10.1016/j.fsi.2019.05.020.
- Liu B, Chen R, Zhao M, Zhang X, Wang J, Gao L, Xu J, Wu Q, Ning N. Vaccine confidence in China after the Changsheng vaccine incident: a cross-sectional study. BMC Public Health. 2019;19:1564. doi:10.1186/s12889-019-7945-0.
- Wong LP, Wong PF, Megat Hashim MMAA, Han L, Lin Y, Hu Z. Multidimensional social and cultural norms influencing HPV vaccine hesitancy in Asia. Hum Vaccin Immunother. 2020;16(7):1611–22. doi:10.1080/21645515.2020.1756670.
- Thanh LT, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, Mayhew S. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19:305–06. doi:10.1038/d41573-020-00073-5.
- Wee SL. China’s Coronavirus vaccine drive empowers a troubled industry. New York Times. 2020 May 4 [accessed 2020 May 31]. https://www.nytimes.com/2020/05/04/business/coronavirus-china-vaccine.html.
- Becker MH. The health belief model and personal health behavior. Health Educ Monogr. 1974;2(4):324–508. doi:10.1177/109019817400200407.
- China Academy of Information and Communications Technology Industry and Planning Research Institute. WeChat economic and social impact report 2017. 2018 April [accessed 2021 Sep 26]. http://www.caict.ac.cn/kxyj/qwfb/ztbg/201805/P020180529380481819634.pdf
- Chin WW. The partial least squares approach to structural equation modelling. In: Modern methods for business research (Ed.), Marcoulides , G. A. Mahwah (NJ): Lawrence Erlbaum Associates; 1998. p. 295–336.
- Ringle CM, Wende S, Becker JM. SmartPLS 3.2. 7. Bönningstedt (Germany): SmartPLS GmbH; 2015.
- Kline RB. Principles and practice of structural equation modeling. New York (NY): Guilford Press; 2011.
- Zhao K, Long C, Wang Y, Zeng T, Fu X. Negligible risk of the COVID-19 resurgence caused by work resuming in China (outside Hubei): a statistical probability study. J Public Health (Oxf). 2020:1–2. doi:10.1093/pubmed/fdaa046.
- Verelst F, Willem L, Beutels P. Behavioural change models for infectious disease transmission: a systematic review (2010–2015). J R Soc Interface. 2016;13(125):20160820. doi:10.1098/rsif.2016.0820.
- Facciolà A, Visalli G, Orlando A, Bertuccio MP, Spataro P, Squeri R, Picerno I, Di Pietro A. Vaccine hesitancy: an overview on parents’ opinions about vaccination and possible reasons of vaccine refusal. J Public Health Res. 2019;8:1436. doi:10.4081/jphr.2019.1436.
- Damnjanović K, Graeber J, Ilić S, Lam WY, Ž L, Morales S, Pulkkinen T, Vingerhoets L. Parental decision-making on childhood vaccination. Front Psychol. 2018;9:735. doi:10.3389/fpsyg.2018.00735.
- Zheng Y, Rodewald L, Yang J, Qin Y, Pang M, Feng L, Yu H. The landscape of vaccines in China: history, classification, supply, and price. BMC Infect Dis. 2018;18:1–8. doi:10.1186/s12879-018-3422-0.
- Han B, Song Y, Li C, Yang W, Ma Q, Jiang Z, Li M, Lian X, Jiao W, Wang L, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;S1473-3099(21)00319–4. doi:10.1016/S1473-3099(21)00319-4.
- Zou X, Cao B. COVID-19 vaccines for children younger than 12 years: are we ready? Lancet Infect Dis. 2021:S1473-3099(21)00384–4. doi:10.1016/S1473-3099(21)00384-4.
- U.S. Food & Drug Administration. Coronavirus (COVID-19) update: FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic. 2021 May 10 [accessed 2021 Sep 26]. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use.
- Government Report. Ministry of Health of China: the pandemic H1N1 vaccines should not be charged for any kinds of person. 2009 Oct 3 [accessed 2021 Sep 26]. http://www.gov.cn/jrzg/2009-10/31/content_1453527.htm.
- Huang B. The new China vaccine administration law: re-establishing confidence in vaccines. Biologicals. 2019;61:95–96. doi:10.1016/j.biologicals.2019.08.007.